Heart Test Laboratories
HSCS
19 hedge funds and large institutions have $203K invested in Heart Test Laboratories in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.
900% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 1
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
90% more funds holding
Funds holding: 10 → 19 (+9)
0.03% less ownership
Funds ownership: 0.05% → 0.02% (-0.03%)
12% less capital invested
Capital invested by funds: $232K → $203K (-$28.9K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$56.6K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$43.3K |
| 3 |
FWTB
First Western Trust Bank
Denver,
Colorado
|
+$18.5K |
| 4 |
CF
Cantor Fitzgerald
New York
|
+$12.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$7.59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CD
Chapin Davis
Baltimore,
Maryland
|
-$9.85K |
| 2 |
HF
HRT Financial
New York
|
-$8K |
HSCS Hedge Fund Activity: Q4 2023 in Review
19 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q4 2023, worth a combined $203K — down 12% from $232K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new HSCS positions and 1 closed out — a net gain of 9 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, adding an estimated $56.6K. The largest seller was Chapin Davis, cutting an estimated $9.85K.
- 19 institutional investors held Heart Test Laboratories (HSCS) as of Q4 2023, up from 10 in Q3 2023.
- Funds reported $203K of Heart Test Laboratories stock for Q4 2023, down 12% quarter-over-quarter.
- 10 funds opened new Heart Test Laboratories positions in Q4 2023 and 1 closed out, a net change of +9 holders.
- The largest Heart Test Laboratories buyer in Q4 2023 was Virtu Financial, an estimated $56.6K added.
- The largest Heart Test Laboratories seller in Q4 2023 was Chapin Davis, an estimated $9.85K sold.
Based on aggregated 13F filings for Q4 2023.